| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later
|
Di Meglio, A.
|
|
|
35 |
11 |
p. 1048-1060
|
artikel
|
| 2 |
Advancing rectal cancer therapy: mFOLFIRINOX reduces metastasis and improves survival outcomes. Letter to the Editor regarding ‘Total neoadjuvant therapy with mFOLFIRINOX versus preoperativechemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial’ by Conroy T et al.
|
Shubhra, Q.T.H.
|
|
|
35 |
11 |
p. 1062-1063
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
35 |
11 |
p. iii
|
artikel
|
| 4 |
Efficacy rigor of neoadjuvant therapy: the role and synthesis of tumor subtype analysis. Letter to the Editor regarding ‘Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial’ by Conroy T et al.
|
Li, H.
|
|
|
35 |
11 |
p. 1064-1065
|
artikel
|
| 5 |
Elevating cancer on the global health agenda: towards the fourth high-level meeting on NCDs 2025
|
Casolino, R.
|
|
|
35 |
11 |
p. 933-935
|
artikel
|
| 6 |
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer ☆
|
Van Gorp, T.
|
|
|
35 |
11 |
p. 968-980
|
artikel
|
| 7 |
ESMO Recommendations on clinical reporting of genomic test results for solid cancers
|
van de Haar, J.
|
|
|
35 |
11 |
p. 954-967
|
artikel
|
| 8 |
Interpretation of long-term overall survival from the PRODIGE 23 study. Letter to the Editor regarding ‘Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial’, by T. Conroy et al
|
Moretto, R.
|
|
|
35 |
11 |
p. 1063-1064
|
artikel
|
| 9 |
KEYNOTE-B21: a missed opportunity or a turning point in adjuvant immunotherapy for dMMR endometrial cancer?
|
Lorusso, D.
|
|
|
35 |
11 |
p. 925-927
|
artikel
|
| 10 |
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022 ☆
|
Freedman, R.A.
|
|
|
35 |
11 |
p. 993-1002
|
artikel
|
| 11 |
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial ☆
|
Monk, B.J.
|
|
|
35 |
11 |
p. 981-992
|
artikel
|
| 12 |
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
|
Tannir, N.M.
|
|
|
35 |
11 |
p. 1026-1038
|
artikel
|
| 13 |
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
|
Bercz, A.
|
|
|
35 |
11 |
p. 1003-1014
|
artikel
|
| 14 |
Paving the path towards tissue-agnostic drug approval in oncology
|
Le Tourneau, C.
|
|
|
35 |
11 |
p. 930-932
|
artikel
|
| 15 |
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma ☆
|
Kim, T.M.
|
|
|
35 |
11 |
p. 1039-1047
|
artikel
|
| 16 |
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY ☆
|
Kataoka, K.
|
|
|
35 |
11 |
p. 1015-1025
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
35 |
11 |
p. i-ii
|
artikel
|
| 18 |
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
|
Westphalen, C.B.
|
|
|
35 |
11 |
p. 936-953
|
artikel
|
| 19 |
TNT for organ preservation in rectal cancer: still looking for the right schedule and patient
|
Grotenhuis, B.A.
|
|
|
35 |
11 |
p. 928-929
|
artikel
|
| 20 |
Tumour heterogeneity in molecular imaging for breast cancer
|
Lobo-Martins, S.
|
|
|
35 |
11 |
p. 1061-1062
|
artikel
|
Tijdschrift beschrijving